Aarkstore Enterprise-Asthma – pipeline review, h2 2012

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Asthma – Pipeline Review, H2 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Asthma - Pipeline Review, Global Markets Direct’s, Asthma -
Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic
pipeline. This report provides information on the therapeutic development for
Asthma, complete with latest updates, and special features on late-stage and
discontinued projects. It also reviews key players involved in the therapeutic
development for Asthma. Asthma - Pipeline Review, Half Year is built using data and
information sourced from Global Markets Direct’s proprietary databases,
Company/University websites, SEC filings, investor presentations and featured
press releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Asthma.
- A review of the Asthma products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.

2. Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Asthma.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
Table of contents:
List of Tables 7
List of Figures 11
Introduction 12
Global Markets Direct Report Coverage 12
Asthma Overview 13
Therapeutics Development 14
An Overview of Pipeline Products for Asthma 14
Asthma Therapeutics under Development by Companies 16
Asthma Therapeutics under Investigation by Universities/Institutes 27
Late Stage Products 30
Comparative Analysis 30
Mid Clinical Stage Products 31
Comparative Analysis 31
Early Clinical Stage Products 32
Comparative Analysis 32
Discovery and Pre-Clinical Stage Products 33
Comparative Analysis 33
Asthma Therapeutics – Products under Development by Companies 34
Asthma Therapeutics – Products under Investigation by Universities/Institutes 48
Companies Involved in Asthma Therapeutics Development 50
Alcon, Inc. 50
List of Figures

3. List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1
Liver Cancer – Pipeline Review, H2 2012
Non-Small Cell Lung Cancer – Pipeline Review, H2 2012
Asthma – Pipeline Review, H2 2012
Multiple Sclerosis – Pipeline Review, H2 2012
Gastrointestinal Tract Cancer – Pipeline Review, H2 2012
Diabetes – Pipeline Review, H2 2012
Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review,
H2 2012
Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012
Malaria – Pipeline Review, H2 2012
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review,
H2 2012
Dermatitis – Pipeline Review, H2 2012

4. Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com